Compare ASND & GEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASND | GEN |
|---|---|---|
| Founded | 2006 | 1982 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.6B | 14.8B |
| IPO Year | 2014 | 1995 |
| Metric | ASND | GEN |
|---|---|---|
| Price | $232.30 | $22.62 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 7 |
| Target Price | ★ $277.13 | $35.29 |
| AVG Volume (30 Days) | 694.9K | ★ 7.2M |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.19% |
| EPS Growth | N/A | ★ 7.29 |
| EPS | N/A | ★ 0.74 |
| Revenue | N/A | ★ $6,676,000,000.00 |
| Revenue This Year | $98.99 | $27.37 |
| Revenue Next Year | $41.45 | $5.51 |
| P/E Ratio | ★ N/A | $30.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $124.06 | $21.33 |
| 52 Week High | $242.00 | $32.22 |
| Indicator | ASND | GEN |
|---|---|---|
| Relative Strength Index (RSI) | 57.40 | 41.68 |
| Support Level | $190.49 | $22.14 |
| Resistance Level | $242.00 | $27.24 |
| Average True Range (ATR) | 9.59 | 0.77 |
| MACD | 0.44 | 0.02 |
| Stochastic Oscillator | 81.29 | 32.62 |
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
Gen is a cybersecurity pure-play that offers security, identity protection, and privacy solutions to individual consumers. The firm's cyber safety offerings, via brands such as Norton, Avast, and LifeLock, have long maintained their positions as some of the most recognizable consumer-focused security and identity-protection products.